Edesa Biotech (EDSA) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free EDSA Stock Alerts $4.33 -0.07 (-1.59%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Edesa Biotech Short Interest DataCurrent Short Interest11,200 sharesPrevious Short Interest16,100 sharesChange Vs. Previous Month-30.43%Dollar Volume Sold Short$50,512.00Short Interest Ratio1.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares3,220,000 sharesFloat Size2,360,000 sharesShort Percent of Float0.47%Today's Trading Volume3,736 sharesAverage Trading Volume10,721 sharesToday's Volume Vs. Average35% Short Selling Edesa Biotech ? Sign up to receive the latest short interest report for Edesa Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEDSA Short Interest Over TimeEDSA Days to Cover Over TimeEDSA Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Edesa Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202411,200 shares $50,512.00 -30.4%0.5%1.3 $4.51 4/30/202416,100 shares $71,532.30 +5.9%0.7%1.5 $4.44 4/15/202415,200 shares $62,624.00 -22.1%0.7%1.2 $4.12 3/31/202419,500 shares $81,738.15 +10.2%0.8%1.4 $4.19 3/15/202417,700 shares $77,703.00 +4.1%0.8%1.2 $4.39 2/29/202417,000 shares $77,860.00 +11.8%0.7%0.6 $4.58 Get the Latest News and Ratings for EDSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/15/202415,200 shares $85,880.00 -27.6%0.7%0.5 $5.65 1/31/202421,000 shares $93,450.00 +2,525.0%0.9%0.7 $4.45 1/15/2024800 shares $3,728.00 -93.4%0.0%0 $4.66 12/31/202312,100 shares $55,297.00 -61.7%0.5%0.1 $4.57 12/15/202331,600 shares $164,004.00 +1,404.8%1.4%0.3 $5.19 11/30/20232,100 shares $6,930.00 -91.0%0.1%0 $3.30 11/15/202323,200 shares $67,280.00 -21.6%1.1%0.3 $2.90 10/31/202329,600 shares $95,312.00 -50.3%1.4%0.4 $3.22 10/15/202359,500 shares $235,322.50 -80.2%2.8%0.8 $3.96 9/30/2023300,200 shares $1.33 million -4.9%N/A3.5 $4.42 9/15/2023315,500 shares $283,950.00 -0.9%N/A6.5 $0.90 8/31/2023318,200 shares $269,515.40 -49.7%N/A5.8 $0.85 8/15/2023632,100 shares $537,285.00 -1.4%N/A11.5 $0.85 7/31/2023641,300 shares $525,866.00 -0.1%N/A10.8 $0.82 7/15/2023641,700 shares $534,471.93 -3.2%N/A8.9 $0.83 6/30/2023662,800 shares $530,240.00 +5.0%N/A9.6 $0.80 6/15/2023631,000 shares $542,218.30 -0.1%N/A8.7 $0.86 5/31/2023631,800 shares $574,938.00 -1.2%N/A7.9 $0.91 5/15/2023639,600 shares $562,911.96 -12.4%N/A8 $0.88 4/30/2023730,500 shares $818,160.00 -20.0%N/A8.6 $1.12 4/15/2023913,300 shares $958,965.00 +0.8%N/A9.5 $1.05 3/31/2023906,500 shares $826,818.65 +10.9%N/A4.9 $0.91 3/15/2023817,300 shares $980,760.00 +19.3%N/A1.7 $1.20 2/28/2023685,300 shares $979,979.00 +6.3%N/A1.4 $1.43 2/15/2023644,500 shares $928,080.00 -17.6%N/A1.3 $1.44 1/31/2023781,700 shares $1.17 million +16.7%N/A1.6 $1.50 1/15/2023669,600 shares $1.69 million -17.8%N/A1.4 $2.52 12/30/2022815,000 shares $1.76 million +111.0%N/A2.1 $2.16 12/15/2022386,300 shares $370,732.11 +4.4%3.2%0.9 $0.96 11/30/2022369,900 shares $341,121.78 +4.3%3.9%1.9 $0.92 11/15/2022354,800 shares $325,316.12 +6.2%3.7%1.8 $0.92 10/31/2022334,000 shares $344,020.00 +10.5%3.5%1.7 $1.03 10/15/2022302,300 shares $292,535.71 +484.7%3.0%1.5 $0.97 9/30/202251,700 shares $47,631.21 -38.7%0.5%0.3 $0.92The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/202284,300 shares $148,368.00 -11.9%0.8%1.2 $1.76 8/31/202295,700 shares $179,916.00 +476.5%1.0%1.3 $1.88 8/15/202216,600 shares $32,536.00 -73.7%0.2%0.2 $1.96 7/31/202263,000 shares $113,400.00 -5.8%0.6%0.9 $1.80 7/15/202266,900 shares $109,716.00 -22.9%0.7%1.2 $1.64 6/30/202286,800 shares $139,748.00 -26.4%0.9%1.4 $1.61 6/15/2022117,900 shares $200,430.00 +12.7%1.2%2 $1.70 5/31/2022104,600 shares $215,476.00 -18.9%1.0%1.5 $2.06 5/15/2022129,000 shares $241,230.00 -13.4%1.3%1.8 $1.87 4/30/2022149,000 shares $330,780.00 -1.9%1.6%2.1 $2.22 4/15/2022151,900 shares $429,877.00 +13.7%1.6%2 $2.83 3/31/2022133,600 shares $396,792.00 -42.7%1.5%1.5 $2.97 3/15/2022233,000 shares $719,970.00 -14.1%2.7%2.3 $3.09 2/28/2022271,300 shares $1.01 million -8.3%3.1%2.7 $3.71 2/15/2022295,900 shares $1.19 million -8.5%3.3%2.6 $4.02 1/31/2022323,300 shares $1.34 million +8.8%4.3%2.6 $4.14 1/15/2022297,300 shares $1.56 million +14.2%4.0%2 $5.26 12/31/2021260,300 shares $1.47 million -3.6%3.5%1 $5.63 12/15/2021270,100 shares $1.44 million -21.3%3.6%0.8 $5.34 11/30/2021343,100 shares $2.17 million -5.0%4.6%0.1 $6.32 11/15/2021361,100 shares $2.48 million -27.5%4.9%0.1 $6.86 10/29/2021498,100 shares $4.09 million -16.0%6.7%0.2 $8.22 10/15/2021593,200 shares $4.63 million -6.9%8.0%0.2 $7.81 9/30/2021637,000 shares $4.70 million +333.0%8.6%0.2 $7.38 9/15/2021147,100 shares $801,695.00 +87.2%2.0%0 $5.45 8/31/202178,600 shares $461,382.00 +216.9%1.1%0.8 $5.87 8/13/202124,800 shares $113,832.00 +19.2%0.3%0.2 $4.59 7/30/202120,800 shares $103,792.00 +17.5%0.3%0.2 $4.99 7/15/202117,700 shares $86,730.00 -35.6%0.2%0.1 $4.90 6/30/202127,500 shares $145,200.00 -19.4%0.4%0.2 $5.28 6/15/202134,100 shares $188,232.00 -35.2%0.5%0.2 $5.52 5/28/202152,600 shares $329,802.00 -60.1%0.7%0.3 $6.27 5/14/2021131,900 shares $774,253.00 +143.8%N/A0.5 $5.87 4/30/202154,100 shares $300,255.00 -30.7%N/A0.2 $5.55 4/15/202178,100 shares $426,426.00 -11.9%N/A0.1 $5.46 3/31/202188,600 shares $465,150.00 +180.4%N/A0.1 $5.25 3/15/202131,600 shares $176,960.00 -88.2%0.5%0.1 $5.60 2/26/2021268,800 shares $1.78 million +202.0%4.7%0.5 $6.61 2/12/202189,000 shares $623,890.00 -49.7%2.2%0.2 $7.01 1/29/2021176,900 shares $999,485.00 +784.5%4.5%0.4 $5.65 1/15/202120,000 shares $99,000.00 +34.2%0.5%0 $4.95 12/31/202014,900 shares $64,368.00 -39.4%0.4%0.1 $4.32 12/15/202024,600 shares $122,505.54 -13.7%0.8%0.2 $4.98 11/30/202028,500 shares $150,195.00 -43.7%0.9%0.2 $5.27 11/15/202050,600 shares $271,216.00 -1.9%1.7%0.2 $5.36 10/30/202051,600 shares $323,532.00 -32.6%1.7%0.2 $6.27 10/15/202076,500 shares $569,160.00 -21.8%2.5%0.1 $7.44 9/30/202097,800 shares $789,246.00 +36.0%3.2%0.1 $8.07 9/15/202071,900 shares $504,738.00 -31.5%2.5%0.1 $7.02 8/31/2020104,900 shares $978,717.00 +28.1%3.2%0.1 $9.33The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 8/14/202081,900 shares $573,300.00 +7.8%2.8%0 $7.00 7/31/202076,000 shares $520,600.00 +46.4%2.8%0 $6.85 7/15/202051,900 shares $244,449.00 -30.2%1.9%0 $4.71 6/30/202074,400 shares $360,096.00 +1,330.8%2.8%0.1 $4.84 6/15/20205,200 shares $30,160.00 -62.3%0.2%0 $5.80 5/29/202013,800 shares $42,366.00 -37.8%0.5%0.2 $3.07 5/15/202022,200 shares $60,828.00 +85.0%0.8%0.4 $2.74 4/30/202012,000 shares $29,400.00 +96.7%0.4%0.2 $2.45 4/15/20206,100 shares $14,335.00 -28.2%0.2%0.1 $2.35 3/31/20208,500 shares $20,230.00 -79.3%0.3%0.2 $2.38 3/13/202041,100 shares $94,530.00 +82.7%1.5%1.4 $2.30 2/28/202022,500 shares $41,625.00 +389.1%0.8%0.4 $1.85 2/14/20204,600 shares $11,178.00 -76.0%0.2%0.1 $2.43 1/31/202019,200 shares $58,944.00 -18.3%0.7%0.5 $3.07 1/15/202023,500 shares $74,495.00 +1.3%0.9%0.6 $3.17 12/31/201923,200 shares $71,920.00 +28.2%0.8%0.6 $3.10 EDSA Short Interest - Frequently Asked Questions What is Edesa Biotech's current short interest? Short interest is the volume of Edesa Biotech shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 11,200 shares of EDSA short. 0.47% of Edesa Biotech's shares are currently sold short. Learn More on Edesa Biotech's current short interest. What is a good short interest ratio for Edesa Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDSA shares currently have a short interest ratio of 1.0. Learn More on Edesa Biotech's short interest ratio. What is a good short interest percentage for Edesa Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of Edesa Biotech's floating shares are currently sold short. Is Edesa Biotech's short interest increasing or decreasing? Edesa Biotech saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 11,200 shares, a drop of 30.4% from the previous total of 16,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edesa Biotech's float size? Edesa Biotech currently has issued a total of 3,220,000 shares. Some of Edesa Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edesa Biotech currently has a public float of 2,360,000 shares. How does Edesa Biotech's short interest compare to its competitors? 0.47% of Edesa Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Edesa Biotech: Rockwell Medical, Inc. (2.11%), Anebulo Pharmaceuticals, Inc. (0.07%), Tharimmune, Inc. (0.17%), Kezar Life Sciences, Inc. (5.10%), Equillium, Inc. (1.61%), Eagle Pharmaceuticals, Inc. (9.97%), CASI Pharmaceuticals, Inc. (0.83%), Aadi Bioscience, Inc. (5.54%), Kronos Bio, Inc. (1.67%), Lexaria Bioscience Corp. (1.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Edesa Biotech stock? Short selling EDSA is an investing strategy that aims to generate trading profit from Edesa Biotech as its price is falling. EDSA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edesa Biotech? A short squeeze for Edesa Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EDSA, which in turn drives the price of the stock up even further. How often is Edesa Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDSA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Rockwell Medical Short Interest Data Anebulo Pharmaceuticals Short Interest Data Tharimmune Short Interest Data Kezar Life Sciences Short Interest Data Equillium Short Interest Data Eagle Pharmaceuticals Short Interest Data CASI Pharmaceuticals Short Interest Data Aadi Bioscience Short Interest Data Kronos Bio Short Interest Data Lexaria Bioscience Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDSA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.